Open access
126
Views
5
CrossRef citations to date
0
Altmetric
Original Research
Potential resource and cost saving analysis of subcutaneous versus intravenous administration for rituximab in non-Hodgkin’s lymphoma and for trastuzumab in breast cancer in 17 Italian hospitals based on a systematic survey
Clemente Ponzetti1 Group Policlinic Monza, Alessandria, National Scientific Associazione Nazionale dei Medici delle Direzioni Ospedaliere (National Association of Hospital Physicians), Bologna, Italy
, Monica Canciani2 Studio EmmEffe S.r.l, Milan, Italy
, Massimo Farina2 Studio EmmEffe S.r.l, Milan, ItalyCorrespondence[email protected]
, Sara Era3 Roche S.p.a., Monza, Italy
& Stefan Walzer4 MArS Market Access and Pricing Strategy GmbH, Weil am Rhein, Loerrach, Germany;5 Health Care Management, State University Baden-Wuerttemberg, Loerrach, Germany
Pages 227-233
|
Published online: 23 May 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.